Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 789871, 9 pages
http://dx.doi.org/10.1093/ecam/nep233
Original Article

Ameliorative Effect of Active Principle Isolated from Seeds of Eugenia jambolana on Carbohydrate Metabolism in Experimental Diabetes

1Department of Biochemistry, University College of Medical Sciences, University of Delhi, Delhi 110095, India
2B-164, Sector 14, Noida, India

Received 26 May 2009; Accepted 25 November 2009

Copyright © 2011 Suman Bala Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. King, R. E. Aubert, and W. H. Herman, “Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections,” Diabetes Care, vol. 21, no. 9, pp. 1414–1431, 1998. View at Google Scholar
  2. R. Pradeepa, R. Deepa, and V. Mohan, “Epidemiology of diabetes in India—current perspective and future projections,” Journal of the Indian Medical Association, vol. 100, no. 3, pp. 144–148, 2002. View at Google Scholar
  3. R. Taylor and L. Agius, “The biochemistry of diabetes,” Biochemical Journal, vol. 250, no. 3, pp. 625–640, 1988. View at Google Scholar
  4. G. F. Cahill Jr., J. Ashmore, A. E. Renold, and A. B. Hastings, “Blood glucose and the liver,” The American Journal of Medicine, vol. 26, no. 2, pp. 264–282, 1959. View at Google Scholar
  5. A. K. Tiwari and J. M. Rao, “Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects,” Current Science, vol. 83, no. 1, pp. 30–38, 2002. View at Google Scholar
  6. A.-U. Rahman and K. Zaman, “Medicinal plants with hypoglycemic activity,” Journal of Ethnopharmacology, vol. 26, no. 1, pp. 1–55, 1989. View at Google Scholar
  7. R. J. Marles and N. R. Farnsworth, “Antidiabetic plants and their active constituents,” Phytomedicine, vol. 2, no. 2, pp. 137–189, 1995. View at Google Scholar
  8. H. X. Wang and T. B. Ng, “Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic activities,” Life Sciences, vol. 65, no. 25, pp. 2663–2677, 1999. View at Google Scholar
  9. W. L. Li, H. C. Zheng, J. Bukuru, and N. De Kimpe, “Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus,” Journal of Ethnopharmacology, vol. 92, no. 1, pp. 1–21, 2004. View at Publisher · View at Google Scholar · View at PubMed
  10. H. A. H. Kataya and A. A. Hamza, “Red cabbage (Brassica oleracea) ameliorates diabetic nephropathy in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 3, pp. 281–287, 2008. View at Publisher · View at Google Scholar · View at PubMed
  11. I. S. R. Punitha, K. Rajendran, A. Shirwaikar, and A. Shirwaikar, “Alcoholic stem extract of Coscinium fenestratum regulates carbohydrate metabolism and improves antioxidant status in streptozotocin-nicotinamide induced diabetic rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 3, pp. 375–381, 2005. View at Publisher · View at Google Scholar · View at PubMed
  12. S. Samane, J. Noël, Z. Charrouf, H. Amarouch, and P. S. Haddad, “Insulin-sensitizing and anti-proliferative effects of Argania spinosa seed extracts,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 3, pp. 317–327, 2006. View at Publisher · View at Google Scholar · View at PubMed
  13. M. Bhat, S. K. Kothiwale, A. R. Tirmale, S. Y. Bhargava, and B. N. Joshi, “Antidiabetic properties of Azardiracta indica and Bougainvillea spectabilis: in vivo studies in murine diabetes model,” Evidence-Based Complementary and Alternative Medicine, 2009. View at Google Scholar
  14. N. K. Rao and S. Nammi, “Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats,” BMC Complementary and Alternative Medicine, vol. 6, article 17, 2006. View at Publisher · View at Google Scholar · View at PubMed
  15. M. Bhat, S. S. Zinjarde, S. Y. Bhargava, A. R. Kumar, and B. N. Joshi, “Antidiabetic Indian plants: a good source of potent amylase inhibitors,” Evidence-Based Complementary and Alternative Medicine, 2008. View at Publisher · View at Google Scholar · View at PubMed
  16. “WHO Expert Committee on Diabetes Mellitus: second report,” World Health Organization - Technical Report Series, vol. 646, pp. 1–80, 1980.
  17. R. N. Chopra, I. C. Chopra, K. L. Handa, and L. D. Kapur, Indigenous Drugs of India, U.N. Dhur and Sons Pvt. Ltd, Calcutta, India, 2nd edition, 1958.
  18. D. S. Shrotri, M. Kelkar, V. K. Deshmukh, and R. Aiman, “Investigation of the hypoglycemic properties of Vinca rosea, Cassia auriculata and Eugenia jambolana,” Indian Journal of Medical Research, vol. 51, pp. 464–467, 1963. View at Google Scholar
  19. R. Bansal, N. Ahmad, and J. R. Kidwai, “Effects of oral administration of Eugenia jambolana seeds and chloropropamide on blood glucose level and pancreatic cathepsin B in rat,” Indian Journal of Biochemistry and Biophysics, vol. 18, no. 5, p. 377, 1981. View at Google Scholar
  20. S. Achrekar, G. S. Kaklij, M. S. Pote, and S. M. Kelkar, “Hypoglycemic activity of Eugenia jambolana and Ficus bengalensis: mechanism of action,” In Vivo, vol. 5, no. 2, pp. 143–147, 1991. View at Google Scholar
  21. J. K. Grover, V. Vats, and S. S. Rathi, “Anti-hyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism,” Journal of Ethnopharmacology, vol. 73, no. 3, pp. 461–470, 2000. View at Publisher · View at Google Scholar
  22. V. Vikrant, J. K. Grover, N. Tandon, S. S. Rathi, and N. Gupta, “Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats,” Journal of Ethnopharmacology, vol. 76, no. 2, pp. 139–143, 2001. View at Publisher · View at Google Scholar
  23. S. B. Sharma, A. Nasir, K. M. Prabhu, P. S. Murthy, and G. Dev, “Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits,” Journal of Ethnopharmacology, vol. 85, no. 2-3, pp. 201–206, 2003. View at Publisher · View at Google Scholar
  24. K. Ravi, K. Sivagnanam, and S. Subramanian, “Anti-diabetic activity of Eugenia jambolana seed kernels on streptozotocin-induced diabetic rats,” Journal of Medicinal Food, vol. 7, no. 2, pp. 187–191, 2004. View at Publisher · View at Google Scholar · View at PubMed
  25. K. Ravi, S. Rajasekaran, and S. Subramanian, “Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats,” Food and Chemical Toxicology, vol. 43, no. 9, pp. 1433–1439, 2005. View at Publisher · View at Google Scholar · View at PubMed
  26. S. B. Sridhar, U. D. Sheetal, M. R. S. M. Pai, and M. S. Shastri, “Preclinical evaluation of the antidiabetic effect of Eugenia jambolana seed powder in streptozotocin-diabetic rats,” Brazilian Journal of Medical and Biological Research, vol. 38, no. 3, pp. 463–468, 2005. View at Google Scholar
  27. B. Sharma, C. Balomajumder, and P. Roy, “Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats,” Food and Chemical Toxicology, vol. 46, no. 7, pp. 2376–2383, 2008. View at Publisher · View at Google Scholar · View at PubMed
  28. K. R. Kohli and R. H. Singh, “Eugenia jambolana: a plant drug with potential antidiabetic properties,” Journal of Scientific Research on Plant Medicine, vol. 6, pp. 1–4, 1985. View at Google Scholar
  29. R. Shukla, K. Anand, K. M. Prabhu, and P. S. Murthy, “Hypoglycaemic effect of the water extract of Ficus bengalensis in alloxan recovered, mildly diabetic and severely diabetic rabbits,” International Journal of Diabetes in Developing Countries, vol. 14, pp. 78–81, 1994. View at Google Scholar
  30. D. Barham and P. Trinder, “An improved colour reagent for the determination of blood glucose by the oxidase system,” The Analyst, vol. 97, no. 1151, pp. 142–145, 1972. View at Google Scholar
  31. D. E. Goldstein, R. R. Little, H. M. Wiedmeyer, J. D. England, and E. M. McKenzie, “Glycated hemoglobin: methodologies and clinical applications,” Clinical Chemistry, vol. 32, no. 10, pp. B64–B70, 1986. View at Google Scholar
  32. S. B. Sharma, A. Nasir, K. M. Prabhu, and P. S. Murthy, “Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus,” Journal of Ethnopharmacology, vol. 104, no. 3, pp. 367–373, 2006. View at Publisher · View at Google Scholar · View at PubMed
  33. W. Burgi, M. Briner, N. Franken, and A.-C. Kessler, “One-step sandwich enzyme immunoassay for insulin using monoclonal antibodies,” Clinical Biochemistry, vol. 21, no. 5, pp. 311–314, 1988. View at Google Scholar
  34. E. V. Porter and B. M. Chassy, “Glucokinase from Streptococcus mutant,” in Methods in Enzymology, W. A. Wood, Ed., pp. 25–31, Academic Press, London, UK, 1982. View at Google Scholar
  35. E. Racker, “Photometric measurements of hexokines and phosphohexokinase activity,” The Journal of Biological Chemistry, vol. 167, pp. 843–854, 1947. View at Google Scholar
  36. A. E. Harper, “Measurement of enzyme activity: glucose-6-phosphatase,” in Methods of Enzymatic Analysis, H. U. Bergmeyer, Ed., pp. 788–792, Academic Press, New York, NY, USA, 1965. View at Google Scholar
  37. E. Racker and E. A. R. Schroeder, “The reductive pentose phosphate cycle. II. Specific C-1 phosphatases for fructose 1,6-diphosphate and sedoheptulose 1,7-diphosphate,” Archives of Biochemistry and Biophysics, vol. 74, no. 2, pp. 326–344, 1958. View at Google Scholar
  38. N. V. Carroll, R. W. Longley, and J. H. Roe, “The determination of glycogen in liver and muscles by the anthrone reagent,” The Journal of Biological Chemistry, vol. 220, pp. 583–587, 1956. View at Google Scholar
  39. R. J. Koenig, C. M. Peterson, and C. Kilo, “Hemoglobin AIc as an indicator of the degree of glucose intolerance in diabetes,” Diabetes, vol. 25, no. 3, pp. 230–232, 1976. View at Google Scholar
  40. A. T. Chang and J Noble, “Estimation of HbA1c like glycosylated proteins in kidneys of streptozotocin diabetes and controlled rats,” Diabetes, vol. 28, pp. 408–415, 1979. View at Google Scholar
  41. B. A. Khan, A. Abraham, and S. Leelamma, “Hypoglycemic action of Murraya koenigii (curry leaf) and Brassica juncea (mustard): mechanism of action,” Indian Journal of Biochemistry and Biophysics, vol. 32, no. 2, pp. 106–108, 1995. View at Google Scholar
  42. N. R. Katz, M. A. Nauck, and P. T. Wilson, “Induction of glucokinase by insulin under the permissive action of dexamethasone in primary rat hepatocyte cultures,” Biochemical and Biophysical Research Communications, vol. 88, no. 1, pp. 23–29, 1979. View at Google Scholar
  43. C. Minassian and G. Mithieux, “Differential time course of liver and kidney glucose-6 phosphatase activity during fasting in rats,” Comparative Biochemistry and Physiology B, vol. 109, no. 1, pp. 99–104, 1994. View at Publisher · View at Google Scholar
  44. B. L. Horecker, E. Melloni, and S. Pontremoli, “Fructose 1,6-bisphosphatase: properties of the neutral enzyme and its modification by proteolytic enzymes,” Advances in Enzymology, vol. 42, pp. 193–226, 1975. View at Google Scholar
  45. N. Z. Baquer, D. Gupta, and J. Raju, “Regulation of metabolic pathways in liver and kidney during experimental diabetes: effects of antidiabetic compounds,” Indian Journal of Clinical Biochemistry, vol. 13, no. 2, pp. 63–80, 1998. View at Google Scholar
  46. W. T. Garvey, “Glucose transport and NIDDM,” Diabetes Care, vol. 15, no. 3, pp. 396–417, 1992. View at Google Scholar
  47. S. Pugazhenthi, R. L. Khandelwal, and J. F. Anget, “Insulin like effects of vandate on malic enzymes and glucose-6-phosphate dehydrogenase activities in streptozotocin induced diabetic rat liver,” Biochimica et Biophysica Acta, vol. 1083, pp. 310–312, 1991. View at Google Scholar
  48. H. Hikino, M. Kobayashi, Y. Suzuki, and C. Konno, “Mechanisms of hypoglycemic activity of aconitan A, a glycan from aconitum carmichaeli roots,” Journal of Ethnopharmacology, vol. 25, no. 3, pp. 295–304, 1989. View at Google Scholar